Digestive Disease Week 2020: Intracystic Injection of Submicron Particle Paclitaxel (SPP) for the Treatment of Mucinous Pancreatic Cystic Lesions Resulted in Reduction in Cyst Volume, an Interim Report (Mohamed O. Othman)
Digestive Disease Week 2020: EUS-guided Injection of Intratumoral Submicron Particle Paclitaxel (SPP) for the Treatment of Locally Advanced Pancreatic Adenocarcinoma (LAPC) – Phase 2 Study (Neil Sharma, MD)
Video Highlights: NanoPac Injection for Pancreatic Cancer by Neil R. Sharma, MD, Parkview Cancer Institute
Video: NanoPac Injection for Pancreatic Cancer by Neil R. Sharma, MD, Parkview Cancer Institute
ACG 2019 Plenary Presentation: A Novel EUS-guided Intratumoral Delivery of Submicron Particle Paclitaxel for the Treatment of Locally Advanced Pancreatic Cancer.
ACG 2019 Poster: NanoPac-2017-01 Mid-Study Report: Safety, Tolerability and Preliminary Efficacy of Intracyctic Submicron Particle Paclitaxel (SPP) for the Treatment of Pancreatic Mucinous Cysts
American Thoracic Society 2019 Poster: Enhanced Tumor Regression and Immune Cell infiltration by Inhaled Submicron Particle Paclitaxel in an Orthotropic Athymic Nude Rate Model of Non-Small Cell Lung Cancer
